glp-1 weight loss drug news november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Trends: Access & Shortages,
Description
The eligibility criteria top the list and then these points are important
The same physiology that drives these benefits, particularly delayed gastric emptying, also explains many of the complications seen in the ED
Theyve been around for decades, helping treat patients with type 2 diabetes and short bowel syndrome, but when it was discovered that they could also help patients with obesity, they became several household names Ozempic, Wegovy, Mounjaro, etc
She advises people using weight loss drugs to eat a protein-rich diet and participate in regular physical activity, including resistance exercise
Novo Nordisks CagriSema, combining semaglutide with cagrilintide, points to a new generation of higher performance treatments
